Addendum: Treatment of rheumatoid arthritis with biological agents -as a typical and common immune-mediated inflammatory disease [Proc. Jpn. Acad., Ser. B, 93, 8, (600-608)]doi: 10.2183/pjab.93.038

Research output: Contribution to journalComment/debatepeer-review

Abstract

Molecules involved in the disease process facilitated our understanding of pathogenesis of the disease with unknown etiology such as immune-mediated and inflammatory diseases. Moreover, the targeted therapies against the proposed molecular targets by biological agents provide enormous benefits to the patients and societies. Here, I will review recent progress of the biological treatment in the immune-inflammatory diseases by focusing on the rheumatoid arthritis, the disease characterized by persistent polyarthritis leading to joint destruction and disability with autoimmune features, as a role model.

Original languageEnglish
Pages (from-to)56-57
Number of pages2
JournalProceedings of the Japan Academy Series B: Physical and Biological Sciences
Volume94
Issue number1
DOIs
Publication statusPublished - 2018

Keywords

  • Biologics
  • Cytokines
  • Immune-mediated inflammatory diseases
  • Rheumatoid arthritis
  • Therapy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Physics and Astronomy(all)

Fingerprint Dive into the research topics of 'Addendum: Treatment of rheumatoid arthritis with biological agents -as a typical and common immune-mediated inflammatory disease [Proc. Jpn. Acad., Ser. B, 93, 8, (600-608)]doi: 10.2183/pjab.93.038'. Together they form a unique fingerprint.

Cite this